Order Article Reprints

Morfini M, Peyvandi F, Mancuso ME, Marchesini E, Tagliaferri A, Gualtierotti R, Castaman G, Pollio B, Santoro C, Banov L, et al. Pharmacokinetics of Efmoroctocog alfa by Two-Compartment Model Highlights Hemophilia A Patients with Biphasic Decay, Long Mean Residence Time, and Beta Half-Life. Journal of Clinical Medicine. 2024; 13(17):4986. https://doi.org/10.3390/jcm13174986

Morfini, Massimo, Flora Peyvandi, Maria Elisa Mancuso, Emanuela Marchesini, Annarita Tagliaferri, Roberta Gualtierotti, Giancarlo Castaman, Berardino Pollio, Cristina Santoro, Luisa Banov, and et al. 2024. "Pharmacokinetics of Efmoroctocog alfa by Two-Compartment Model Highlights Hemophilia A Patients with Biphasic Decay, Long Mean Residence Time, and Beta Half-Life" Journal of Clinical Medicine 13, no. 17: 4986. https://doi.org/10.3390/jcm13174986

Morfini, M., Peyvandi, F., Mancuso, M. E., Marchesini, E., Tagliaferri, A., Gualtierotti, R., Castaman, G., Pollio, B., Santoro, C., Banov, L., Napolitano, M., Preti, P. S., Santoro, R. C., Coppola, A., Linari, S., Santagostino, E., & Bernardi, F. (2024). Pharmacokinetics of Efmoroctocog alfa by Two-Compartment Model Highlights Hemophilia A Patients with Biphasic Decay, Long Mean Residence Time, and Beta Half-Life. Journal of Clinical Medicine, 13(17), 4986. https://doi.org/10.3390/jcm13174986